Clover Health Investments, Corp.
CLOV
$3.47
-$0.17-4.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.89% | 15.34% | 8.20% | -28.50% | -46.50% |
| Total Other Revenue | 36.27% | 33.21% | 28.61% | 17.96% | 12.18% |
| Total Revenue | 22.12% | 15.62% | 8.52% | -27.99% | -46.07% |
| Cost of Revenue | 22.54% | 10.01% | 0.17% | -38.55% | -55.65% |
| Gross Profit | 20.78% | 34.80% | 40.96% | 52.92% | 68.24% |
| SG&A Expenses | 2.79% | -0.62% | -7.11% | -12.03% | -12.66% |
| Depreciation & Amortization | -17.88% | -41.95% | -46.95% | 67.10% | 78.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.72% | 6.78% | -2.12% | -32.75% | -48.14% |
| Operating Income | 56.27% | 81.13% | 75.08% | 69.32% | 65.87% |
| Income Before Tax | 64.17% | 84.14% | 77.98% | 59.05% | 56.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 64.17% | 84.14% | 77.98% | 59.05% | 56.18% |
| Earnings from Discontinued Operations | 84.03% | 88.22% | 201.37% | 295.48% | -185.70% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.16% | 84.30% | 79.84% | 59.76% | 52.63% |
| EBIT | 56.27% | 81.13% | 75.08% | 69.32% | 65.87% |
| EBITDA | 57.02% | 81.92% | 75.47% | 69.74% | 66.27% |
| EPS Basic | 66.12% | 84.64% | 80.24% | 60.10% | 52.96% |
| Normalized Basic EPS | 57.47% | 81.53% | 75.56% | 69.48% | 66.06% |
| EPS Diluted | 65.66% | 82.38% | 78.55% | 58.67% | 52.10% |
| Normalized Diluted EPS | 57.54% | 81.41% | 75.48% | 69.42% | 66.00% |
| Average Basic Shares Outstanding | 2.68% | 2.01% | 1.85% | 1.51% | 1.19% |
| Average Diluted Shares Outstanding | 2.27% | 2.41% | 2.25% | 1.92% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |